Jeremy Green sold $574K of Fate Therapeutics (FATE)

Executed Dec 20 2024, disclosed Dec 26 2024, 6 days later, against a two-business-day limit.

Value, as filed

$574K

341,633 sh × $1.68

Executed

Dec 20 2024

the trade date, as filed

Disclosed

Dec 26 2024

6 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JG Jeremy Green Director profile →

Jeremy Green (Director) filed 3 Form 4 reports in the past 24 months (3 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in ADCT. Across 3 priced purchase filings, the average 21-session return was -17.6% from execution and -11.5% from disclosure (delay-adjusted; derived). The largest single filing was $669K of FATE (397,964 sh × $1.68, as filed), executed Dec 20 2024.

The name

FATE

Fate Therapeutics, Inc. FATE · Healthcare · 2 filings in 24 months ticker →

Healthcare · Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeremy Green in FATE

FATEPURCHASE Fate Therapeutics, Inc. $669K
397,964 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET †